10760429

Source:http://linkedlifedata.com/resource/pubmed/id/10760429

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001792, umls-concept:C0015133, umls-concept:C0030705, umls-concept:C0079083, umls-concept:C0205420, umls-concept:C0282460, umls-concept:C0441771, umls-concept:C0442027, umls-concept:C0684249, umls-concept:C1522449
pubmed:issue	2
pubmed:dateCreated	2000-7-31
pubmed:abstractText	To investigate feasibility, toxicity, and efficacy of accelerated hyperfractionated radiation therapy and concurrent carboplastin/oral etoposide in elderly (> 70 years) patients with stage III non-small-cell lung cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0360-3016
pubmed:author	pubmed-author:AleksandrovicJJ, pubmed-author:DagovicAA, pubmed-author:JeremicBB, pubmed-author:MilicicBB, pubmed-author:MilisavljevicSS, pubmed-author:NikolicNN, pubmed-author:Radosavljevic-AsicGG, pubmed-author:ShibamotoYY
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	44
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	343-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10760429-Administration, Oral, pubmed-meshheading:10760429-Aged, pubmed-meshheading:10760429-Analysis of Variance, pubmed-meshheading:10760429-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10760429-Carboplatin, pubmed-meshheading:10760429-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:10760429-Combined Modality Therapy, pubmed-meshheading:10760429-Disease-Free Survival, pubmed-meshheading:10760429-Dose Fractionation, pubmed-meshheading:10760429-Drug Administration Schedule, pubmed-meshheading:10760429-Etoposide, pubmed-meshheading:10760429-Feasibility Studies, pubmed-meshheading:10760429-Female, pubmed-meshheading:10760429-Humans, pubmed-meshheading:10760429-Lung Neoplasms, pubmed-meshheading:10760429-Male, pubmed-meshheading:10760429-Neoplasm Staging, pubmed-meshheading:10760429-Sex Factors, pubmed-meshheading:10760429-Survival Analysis
pubmed:year	1999
pubmed:articleTitle	A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.
pubmed:affiliation	Department of Oncology, Belgrade, Yugoslavia.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II